162 related articles for article (PubMed ID: 27629785)
1. Ubiquitin-specific protease 39 is overexpressed in human lung cancer and promotes tumor cell proliferation in vitro.
Lin Z; Xiong L; Lin Q
Mol Cell Biochem; 2016 Nov; 422(1-2):97-107. PubMed ID: 27629785
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT.
Yan C; Yuan J; Xu J; Zhang G; Li X; Zhang B; Hu T; Huang X; Mao Y; Song G
Med Oncol; 2019 Oct; 36(11):95. PubMed ID: 31637536
[TBL] [Abstract][Full Text] [Related]
3. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.
Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Guan W; Zhou J; Wu Y; Qiu Y; Ding Y
Oncol Rep; 2015 Aug; 34(2):823-32. PubMed ID: 26081192
[TBL] [Abstract][Full Text] [Related]
4. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.
Cai J; Liu T; Huang P; Yan W; Guo C; Xiong L; Liu A
Biochem Biophys Res Commun; 2017 Apr; 486(1):184-190. PubMed ID: 28286270
[TBL] [Abstract][Full Text] [Related]
5. Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway.
Yuan J; Zhang G; Li X; Ma Q; Cheng W; Wang W; Zhang B; Hu T; Song G
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255748
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of ubiquitin-specific peptidase 39 inhibited the growth of osteosarcoma cells and induced apoptosis in vitro.
Gan Z; Han K; Lin S; Hu H; Shen Z; Min D
Biol Res; 2017 Apr; 50(1):15. PubMed ID: 28403900
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.
Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X
Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357
[TBL] [Abstract][Full Text] [Related]
8. Lentivirus-mediated inhibition of USP39 suppresses the growth of gastric cancer cells via PARP activation.
Wang X; Yu Q; Huang L; Yu P
Mol Med Rep; 2016 Jul; 14(1):301-6. PubMed ID: 27175747
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation.
Huang Y; Pan XW; Li L; Chen L; Liu X; Lu JL; Zhu XM; Huang H; Yang QW; Ye JQ; Gan SS; Wang LH; Hong Y; Xu DF; Cui XG
Oncotarget; 2016 Apr; 7(16):22016-30. PubMed ID: 26959883
[TBL] [Abstract][Full Text] [Related]
10. USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance.
Wang L; Chen T; Li X; Yan W; Lou Y; Liu Z; Chen H; Cui Z
Int J Oncol; 2019 Jul; 55(1):277-288. PubMed ID: 31180526
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated inhibition of USP39 suppresses the growth of breast cancer cells in vitro.
Wang H; Ji X; Liu X; Yao R; Chi J; Liu S; Wang Y; Cao W; Zhou Q
Oncol Rep; 2013 Dec; 30(6):2871-7. PubMed ID: 24126978
[TBL] [Abstract][Full Text] [Related]
12. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis.
Yuan J; Li X; Zhang G; Cheng W; Wang W; Lei Y; Ma Q; Song G
Mol Carcinog; 2021 Apr; 60(4):265-278. PubMed ID: 33634905
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of ubiquitin‑specific peptidase 39 inhibits the malignant progression of human renal cell carcinoma.
Xu Y; Zhu MR; Zhang JY; Si GM; Lv JJ
Mol Med Rep; 2018 Mar; 17(3):4729-4735. PubMed ID: 29328477
[TBL] [Abstract][Full Text] [Related]
14. miR-381 Inhibits Proliferation and Invasion of Non-Small-Cell Cancer Cells by Targeting USP39.
Cui F; Luo P; Wu R; Meng J
Dis Markers; 2022; 2022():2195393. PubMed ID: 36046375
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro.
Pan Z; Pan H; Zhang J; Yang Y; Liu H; Yang Y; Huang G; Ni J; Huang J; Zhou W
Biol Res; 2015 Mar; 48(1):18. PubMed ID: 25889525
[TBL] [Abstract][Full Text] [Related]
16. USP39 regulates the cell cycle, survival, and growth of human leukemia cells.
Liu C; Yao X; Li M; Xi Y; Zhao L
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898977
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells.
Liu S; Liu X; Wang H; Zhou Q; Liang Y; Sui A; Yao R; Zhao B; Sun M
Oncol Rep; 2015 May; 33(5):2477-83. PubMed ID: 25812575
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of USP39 by lentivirus-mediated RNA interference suppresses the growth of oral squamous cell carcinoma.
Li KY; Zhang J; Jiang LC; Zhang B; Xia CP; Xu K; Chen HY; Yang QZ; Liu SW; Zhu H
Cancer Biomark; 2016; 16(1):137-144. PubMed ID: 26835714
[TBL] [Abstract][Full Text] [Related]
19. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.
Ding K; Ji J; Zhang X; Huang B; Chen A; Zhang D; Li X; Wang X; Wang J
Oncogene; 2019 Sep; 38(37):6414-6428. PubMed ID: 31332287
[TBL] [Abstract][Full Text] [Related]
20. HIST1H3D: A promising therapeutic target for lung cancer.
Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
